HTS heading 2918
41 exclusion requests, from 28 distinct filers, across the 2018–20 tranches.
41
requests filed
1
granted
2.4% (95% CI 0.4–12.6%, n=41)
grant rate, all filers
Cross-tranche — see caution below
2.4% (95% CI 0.4–12.6%, n=41)
excluding mass filers
41 requests
By tranche
| Tranche | Requests | Granted | Denied | Grant rate |
|---|---|---|---|---|
| List 3 | 41 | 1 | 40 | 2.4% (95% CI 0.4–12.6%, n=41) |
The cross-tranche rate above blends processes. Where this heading appears in more than one tranche, use the per-tranche rows. Where a rate reads “n too small”, fewer than 20 requests were decided and no rate is published for it.
Products filed under this heading
Product titles as they appear on the public docket, unedited. These are examples, not a complete list, and their presence here says nothing about their outcome.
- 2 Methyl Benzoyl Benzoate
- PARSOL® EHS (“Octisalate”)
- PARSOL® HMS (Homosalate)
- PARSOL® MCX (Octinoxate)
- Tartaric Acid - granular chemical
- Ethylhexyl Salicylate (Octisalate)
- 4,4"-Oxydipthalic Anhydride
- Acetyl Tributyl Citrate